| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $46.3M | — | +44.7% |
| Cost of Revenue | $22.7M | — | +76.8% |
| Gross Profit | $23.6M | — | +23.2% |
| R&D Expense | $5.9M | — | +21.0% |
| SG&A Expense | $13.5M | — | -9.7% |
| Operating Income | -$8.5M | — | +41.1% |
| Pre-tax Income | -$5.0M | — | -210.3% |
| Income Tax | -$37K | — | -158.7% |
| Net Income | -$5.0M | — | -196.6% |
| EPS (Basic) | -$0.03 | — | -200.0% |
| EPS (Diluted) | -$0.03 | — | -200.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $56.1M | +14.1% | +123.5% |
| Accounts Receivable | $42.7M | +38.5% | +23.9% |
| Inventory | $8.3M | -11.4% | -17.9% |
| Current Assets | $152.0M | +0.4% | +46.5% |
| Total Assets | $304.6M | +0.1% | +19.0% |
| Current Liabilities | $125.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.2M | — | -25.2% |
| Investing Cash Flow | $9.8M | — | +204.3% |
| Financing Cash Flow | $322K | — | +1510.0% |
| +33.3% |
| Long-term Debt | $28.7M | +0.2% | — |
| Total Liabilities | $184.0M | -0.6% | +36.4% |
| Stockholders' Equity | $120.7M | +1.0% | -0.3% |